Traded Dec 15, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 18, 2025 · Filed Nov 19, 2025
A LivaNova director sold $13K of LivaNova shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$13,485
Shares × reported transaction price
13 days after results of Nov 5, 2025, 99 days before results of Feb 25, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +19.4% | +4.7% | +14.7% |
| 30 days | +18.0% | +5.0% | +13.1% |
| 90 days | +26.2% | +5.2% | +21.0% |
| 180 days | +36.5% | +12.4% | +24.1% |
Past results only. Not a forecast.
Traded Dec 15, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Dec 15, 2025 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Dec 15, 2025 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.